Pritelivir mesylate is active against herpes simplex virus types 1 and 2 (IC50: 0.02 μM against HSV1-2). Pritelivir mesylate is an inhibitor of the viral helicase-primase complex. Pritelivir mesylate shows antiviral activity in vitro and in animal models of herpes simplex virus (HSV) infection.
Related Products:
Capecitabine; Lomustine; Nimustine hydrochloride; Thiotepa; KU-55933; Ganetespib; Onalespib; INNO-206 HCl salt; Aldoxorubicin; Pritelivir